PMID- 12850493 OWN - NLM STAT- MEDLINE DCOM- 20040430 LR - 20191210 IS - 1079-9796 (Print) IS - 1079-9796 (Linking) VI - 31 IP - 1 DP - 2003 Jul-Aug TI - Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y. PG - 102-11 AB - Eight hemochromatosis probands with HFE C282Y homozygosity had frequent, severe, or unusual infections and common variable immunodeficiency (CVID) or immunoglobulin (Ig) G subclass deficiency (IgGSD). Thus, we performed serum Ig isotyping and other characterization of 43 additional unselected probands, 5 human leukocyte antigen (HLA)-identical siblings, and 240 consecutive CVID or IgGSD index patients. C282Y allele frequencies were estimated in 58 CVID or IgGSD index patients without hemochromatosis phenotypes and in 341 controls. HLA-A and -B haplotypes and frequencies were determined in all 51 probands, 186 CVID or IgGSD index patients without hemochromatosis phenotypes, and 751 controls. Thirteen unselected probands (30%) had CVID or IgGSD. Among all 21 hemochromatosis probands with CVID (n = 4) or IgGSD (n = 17), Ig subclass deficiency patterns were IgG(1) (n = 5), IgG(1) and IgG(3) (n = 6), IgG(3) (n = 9), and IgG(1), IgG(3), and IgG(4) (n = 1). IgG(2) or IgA deficiency was not detected; one proband had IgM deficiency. Mean values of total IgG, IgG(1), and IgG(3) were significantly lower in probands with CVID or IgGSD. Mean values of age, transferrin saturation, and ferritin at diagnosis and phlebotomy units required to induce iron depletion were similar in probands with or without CVID or IgGSD; phlebotomy had no apparent effect on IgG levels. C282Y frequencies were similar in CVID or IgGSD index cases without hemochromatosis phenotypes and in controls. There was concordance of Ig and hemochromatosis phenotypes in probands and respective HLA-identical siblings. Eight of 240 CVID or IgGSD index patients had hemochromatosis phenotypes and C282Y homozygosity (3 vs 0.7% and 0.2% controls; P < 0.0001, respectively). The frequency of A*03-B*07 was greater in CVID and IgGSD index cases without hemochromatosis phenotypes than in controls (0.0968 vs 0.0546, respectively; P = 0.0032). HLA-A*03-B*07 was the predominant haplotype in probands grouped by presence or absence of CVID or IgGSD. Some probands in each group were A*03-B*07 homozygotes; group A*03-B*07 frequencies were similar. We conclude that serum IgG abnormalities characteristic of CVID or IgGSD are common in hemochromatosis probands, and that the prevalence of hemochromatosis is increased in CVID and IgGSD index cases. These observations could be explained by the increased frequencies of HLA-A*03-B*07 in C282Y homozygotes and in CVID and IgGSD, and by the common occurrence of putative CVID or IgGSD allele(s) on haplotypes bearing C282Y. FAU - Barton, James C AU - Barton JC AD - Southern Iron Disorders Center, Birmingham, AL, USA. ironmd@dnamail.com FAU - Bertoli, Luigi F AU - Bertoli LF FAU - Acton, Ronald T AU - Acton RT LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Blood Cells Mol Dis JT - Blood cells, molecules & diseases JID - 9509932 RN - 0 (HFE protein, human) RN - 0 (HLA Antigens) RN - 0 (Hemochromatosis Protein) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Membrane Proteins) SB - IM MH - Adult MH - Alabama MH - Common Variable Immunodeficiency/complications/epidemiology/*genetics MH - Family Health MH - Female MH - Gene Frequency MH - HLA Antigens/analysis/genetics MH - Hemochromatosis/complications/epidemiology/*genetics MH - Hemochromatosis Protein MH - Histocompatibility Antigens Class I/*genetics MH - Homozygote MH - Humans MH - IgG Deficiency/complications/epidemiology/*genetics MH - Incidence MH - Infections MH - Male MH - Membrane Proteins/*genetics MH - Middle Aged MH - *Mutation, Missense EDAT- 2003/07/10 05:00 MHDA- 2004/05/01 05:00 CRDT- 2003/07/10 05:00 PHST- 2003/07/10 05:00 [pubmed] PHST- 2004/05/01 05:00 [medline] PHST- 2003/07/10 05:00 [entrez] AID - S1079979603001165 [pii] AID - 10.1016/s1079-9796(03)00116-5 [doi] PST - ppublish SO - Blood Cells Mol Dis. 2003 Jul-Aug;31(1):102-11. doi: 10.1016/s1079-9796(03)00116-5.